{"name":"Ajai Chari","slug":"ajai-chari","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPeUE5S3dzME04TmYzTW5fcmxUMnVKd01GU1l6d1BDR1ZRZTBGNHYxdncyYVZUMzA5YXo4RDRkbDE2VmNoQi0zR01pc2ZXRy1RNUl2V1ZWaWs2Smw0RGd4b1A3U2JxN2xwb05YOHlPaG9DZ214cDJGQnhiR3VMalJtN1RIVHpPTTBfcnQ3WnZUck5WYmtXZFF2d3dSN3FveEVTcG9JN1NRa2FOZzdmelE?oc=5","date":"2026-04-07","type":"regulatory","source":"The American Journal of Managed Care® (AJMC®)","summary":"Teclistamab Plus Daratumumab Approval Marks Milestone in Myeloma Care: Ajai Chari, MD - The American Journal of Managed Care® (AJMC®)","headline":"Teclistamab Plus Daratumumab Approval Marks Milestone in Myeloma Care: Ajai Chari, MD - The American Journal of Managed ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNck9RSkJ3YnJ2RXJ2VVo5M2JlZzhtejZhelNXMW1FN3hPakxjYjVWWEhUQ1JqS2c1Z2ZLZV9YYkZ5bGNxNG5Rd1Z5OURKR0w2czRoLXRwcFE4aWhFNzNNTDhqQktaRlFyd2dsbkNCVEV5SEx1bmhVMzVOWUhXVjVOUEt4SEt2VWVwcVdseHRKV3Juekp4SEpKZ2pfM1BFLUdScXRfVi1XQ1hvLXBBbzE1RXc2OA?oc=5","date":"2026-01-23","type":"pipeline","source":"Pharmacy Times","summary":"Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma - Pharmacy Times","headline":"Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQMk1BM25MVDhQZkRTMkJzX0VhN2wtdkhEMEZocFc4X2dwMGJQaVhfYjVYaEdwSnBxU0t5RGxEXzVqWHVvLVNSeHR3MjRmMjRlNmVDd19hVm5QeTdNWU1GRlRrNExoSURoNENtcU1EUGQwSUdETVVUSU9ab240ZHpuczI1YzlqVE55TXhEZWdueW4?oc=5","date":"2025-04-07","type":"pipeline","source":"The American Journal of Managed Care® (AJMC®)","summary":"Advancing MM Care Through Innovation and Equity: Ajai Chari, MD - The American Journal of Managed Care® (AJMC®)","headline":"Advancing MM Care Through Innovation and Equity: Ajai Chari, MD - The American Journal of Managed Care® (AJMC®)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPaDdQLUtueDZLdk9yZ19fT05zUEQ4YmZ2a1ppTGZvdm9nVU5fUGNEX3ZMNjJkRzVTdlJiVUNfV1VOREFQR3ljb1ZFTHZZMWtDSHJxSnZkdk1KOWNMbWVmdENEajlxNVZiWjUtUXNNbFJsUzF2NTJBQ0s2NG5NN0hQU0thbDdDMVg1SVZLaWFQNkdYMDRSWmx4TjBXRFJQLS1xQWRzbVBjSW9NZTd2SzVZZHFDckZ0Q1Jf?oc=5","date":"2025-03-27","type":"pipeline","source":"The American Journal of Managed Care® (AJMC®)","summary":"Optimizing Patient Selection for CAR T, Bispecifics Mitigates Adverse Events in High-Risk MM - The American Journal of Managed Care® (AJMC®)","headline":"Optimizing Patient Selection for CAR T, Bispecifics Mitigates Adverse Events in High-Risk MM - The American Journal of M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQc3BIZUxXZDg4TlZXUko4NnVkaXMtRF9PbXpYejJnQVdKeTNCMG42UEZOUUJ3QUhVQWRHNG9RSG00bTctMFRJVVFZZnhGUHVGZ1VvUk9TNjFQY0g1cDU4ak9Zekk1QzdSeDFDYk0ydVpLVTdjalc1V291ZGl3SVhXU3JTc3N5eDZTaWV5SkhOTnhTX0ZpdFZDS0Q1aGdXYl9heUkwOUpR?oc=5","date":"2022-12-11","type":"pipeline","source":"MedCity News","summary":"J&J Aims to Expand in Multiple Myeloma With First Drug for Novel Target - MedCity News","headline":"J&J Aims to Expand in Multiple Myeloma With First Drug for Novel Target","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPMVlTQkt1azVNSzJtUTFVd2FiclU5NXQxd05wQmZTUUR4cVFEYmxoX05VWUJQTGYwaDZBWXktbWxjdElsOXR0dHlFVVdyVlZVZzBudGZrSUJBU1JaRmwxY0UydzdLUU9lQ2w3QS01OUE2dW5wRnd5SDlxMTRlN09BV1pIWm85ZlNyUUE4bExKMjlwM3I0S3k1SVpDMGxoUXgwaEZj?oc=5","date":"2022-07-13","type":"pipeline","source":"CancerNetwork","summary":"Ajai Chari, MD, Talks Diversity in Multiple Myeloma Research - CancerNetwork","headline":"Ajai Chari, MD, Talks Diversity in Multiple Myeloma Research","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}